Omnipaque Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited t/a ge healthcare - medical diagnostics - iohexol 388 mg/ml equivalent to 180 mg i/ml - solution for injection - 180 mg i/ ml - active: iohexol 388 mg/ml equivalent to 180 mg i/ml excipient: sodium calcium edetate trometamol water for injection

Omnipaque Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited - iohexol 518 mg/ml equivalent to 240 mg i/ml - solution for injection - 240 mg i/ ml - active: iohexol 518 mg/ml equivalent to 240 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.

Omnipaque Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited - iohexol 647 mg/ml equivalent to 300 mg i/ml - solution for injection - 300 mg i/ ml - active: iohexol 647 mg/ml equivalent to 300 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.

Omnipaque Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited - iohexol 755 mg/ml equivalent to 350 mg i/ml - solution for injection - 350 mg i/ ml - active: iohexol 755 mg/ml equivalent to 350 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.

ORALTAG- iohexol for solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

oraltag- iohexol for solution

interpharma praha, a.s. - iohexol (unii: 4419t9mx03) (iohexol - unii:4419t9mx03) - iodine 4.5 g - oraltag is indicated for use in computed tomography of the abdomen and pelvis to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology. limitations of use oraltag is not indicated for diagnostic examination of the gastrointestinal tract. oraltag is contraindicated in patients with a known hypersensitivity to iodinated contrast agents, including iohexol [see warnings and precautions (5.2)] . risk summary there are no human data on risks associated with the use of oraltag during pregnancy. the background risk in the u.s. general population of major birth defects is 2% to 4% and risk of miscarriage is 15% to 20% of clinically recognized pregnancies. in animal reproduction studies, no evidence of fetal harm was observed with intravenous administration of iohexol to rats and rabbits at doses up to 100 times the maximum recommended human intravenous dose. risk summary iohexol administered intravenously is present in human

Omnipaque 350 mg I/ml inj. sol. i.thec./i.arter./i.v. vial Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omnipaque 350 mg i/ml inj. sol. i.thec./i.arter./i.v. vial

ge healthcare bv-srl - iohexol 755 mg/ml - solution for injection - 350 mg i/ml - iohexol 755 mg/ml - iohexol

Omnipaque 350 mg I/ml inj. sol. i.thec./i.arter./i.v. vial Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omnipaque 350 mg i/ml inj. sol. i.thec./i.arter./i.v. vial

ge healthcare bv-srl - iohexol 755 mg/ml - solution for injection - 350 mg i/ml - iohexol 755 mg/ml - iohexol

Omnipaque 350 mg I/ml inj. sol. i.thec./i.arter./i.v. vial Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omnipaque 350 mg i/ml inj. sol. i.thec./i.arter./i.v. vial

ge healthcare bv-srl - iohexol 755 mg/ml - solution for injection - 350 mg i/ml - iohexol 755 mg/ml - iohexol

Omnipaque 300 mg I/ml inj. sol. i.thec./i.arter./i.v. vial Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omnipaque 300 mg i/ml inj. sol. i.thec./i.arter./i.v. vial

ge healthcare bv-srl - iohexol 647 mg/ml - solution for injection - 300 mg i/ml - iohexol 648 mg/ml - iohexol

Omnipaque 300 mg I/ml inj. sol. i.thec./i.arter./i.v. vial Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omnipaque 300 mg i/ml inj. sol. i.thec./i.arter./i.v. vial

ge healthcare bv-srl - iohexol 647 mg/ml - solution for injection - 300 mg i/ml - iohexol 648 mg/ml - iohexol